Details for Patent: 9,701,538

Which drugs does patent 9,701,538 protect, and when does it expire?

Patent 9,701,538 protects GENOSYL and is included in one NDA.

This patent has eight patent family members in five countries.

Summary for Patent: 9,701,538

Title:	Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Abstract:	Various systems, devices, NO.sub.2 absorbents, NO.sub.2 scavengers and NO.sub.2 recuperator for generating nitric oxide are disclosed herein. According to one embodiment, an apparatus for converting nitrogen dioxide to nitric oxide can include a receptacle including an inlet, an outlet, a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material and the absorbent such that nitrogen dioxide in the gas flow is converted to nitric oxide.
Inventor(s):	Fine; David H. (Cocoa Beach, FL), Vasquez; Gregory (Cocoa, FL), Rounbehler; David P. (Lexington, MA)
Assignee:	GENO LLC (Cocoa, FL)
Application Number:	14/294,070
Patent Claim Types: see list of patent claims	Delivery;

Drugs Protected by US Patent 9,701,538

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes			Y

International Family Members for US Patent 9,701,538

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009209181
Canada	2713049
European Patent Office	2247381
Japan	2011510712
Japan	2014221204